Retatrutide for Weigh and Glucose Management

* This product is strictly for laboratory research use only and must not be used for human consumption, medical treatments, or any other non-research purposes.

What is Retatrutide?

Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. This peptide is being studied for its comprehensive effects on weight loss, fat metabolism, and blood sugar regulation.

Mechanism of Action:
By activating GLP-1, GIP, and glucagon receptors, Retatrutide can increase insulin secretion, improve blood glucose control, and promote fat loss by enhancing energy expenditure.

Potential Benefits:

1. Comprehensive Weight Loss: Targets multiple pathways for more effective fat reduction.

2. Enhanced Insulin Sensitivity: Supports glucose metabolism and insulin response.

3. Increased Energy Expenditure: Promotes calorie burning.

4. Improved Metabolic Flexibility: Beneficial for overall metabolic health.

Current Research Areas:

• Obesity and Fat Metabolism: Explored for reducing body fat and enhancing metabolism.

• Blood Glucose Control: Studied for type 2 diabetes management.

• Cardiovascular Health: Potential for reducing heart disease risks.

Dosage and Administration:

• Common Research Dosage: 2.5-10 mg weekly, subcutaneously.

• Timing: Weekly due to long half-life.

Additional Research References:

• ClinicalTrials.gov: Ongoing research studies on Retatrutide (ClinicalTrials).